module.exports = [
    {
        title: "Moderator",
        name: "Jeffrey I. Weitz, MD, FRCP(C)",
        affiliation: `
        Professor of Medicine
        <br/>
        McMaster University
        <br/>
        Hamilton, Ontario, Canada
        `,
        disclosure: `
        Disclosure: Jeffrey I. Weitz, MD, FRCP(C), has disclosed the following relevant financial relationships: 

        <br/>Served as an advisor or consultant for: Bayer AG; Bristol-Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Ionis Pharmaceuticals, Inc.; Janssen Pharmaceuticals; Merck --AMPERSAND--amp; Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Portola Pharmaceuticals, Inc.
        
        <br/><br/>Dr Weitz does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
        
        <br/><br/>Dr Weitz does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
        `
    },
    {
        title: "Panelist",
        name: "Alok A. Khorana, MD",
        affiliation: `
        Professor of Medicine 
        <br/>
        Cleveland Clinic Lerner College of Medicine
        <br/>
        Cleveland, Ohio, United States
        `,
        disclosure: `
        Disclosure: Alok A. Khorana, MD, has disclosed the following relevant financial relationships: 

        <br/>Served as an advisor or consultant for: AngioDynamics; Bayer AG; Halozyme Therapeutics; Janssen Pharmaceuticals; Pfizer Inc.
        
        <br/>Received grants for clinical research from: Amgen Inc.
        
        <br/><br/>Dr Khorana does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
        
        <br/><br/>Dr Khorana does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
        `
    },
    {
        title: "Anticoagulation Management Steering Committee",
        name: "Keith A.A. Fox, MBChB, FRCP, FMedSci",
        affiliation: `
        Professor of Cardiology, University of Edinburgh, Edinburgh, United Kingdom
        `,
        disclosure: `
        Disclosure: Keith A.A. Fox, MBChB, FRCP, FMedSci, has disclosed the following relevant financial relationships:

        <br/>Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Bayer AG; Janssen Pharmaceuticals, Inc.; Regeneron Pharmaceuticals, Inc; Sanofi 
        
        <br/>Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Bayer AG; GlaxoSmithKline; Janssen Pharmaceuticals, Inc. 
        
        <br/>Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Bayer AG; Janssen Pharmaceuticals, Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi
        `
    },
    {
        title: "Anticoagulation Management Steering Committee",
        name: "Craig I. Coleman, PharmD",
        affiliation: `
        Professor, University of Connecticut, Storrs, Connecticut 
        `,
        disclosure: `
        Disclosure: Craig I. Coleman, PharmD, has disclosed the following relevant financial relationships:

        <br/>Served as an advisor or consultant for: Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Janssen Pharmaceuticals, Inc. 
        
        <br/>Served as a speaker or a member of a speakers bureau for: Bayer AG; Janssen Pharmaceuticals, Inc.
        
        <br/>Received grants for clinical research from: Bayer AG; Janssen Pharmaceuticals, Inc.; Zoll Medical Corporation
        `
    },
    {
        title: "Anticoagulation Management Steering Committee",
        name: "Gilles Montalescot, MD, PhD",
        affiliation: `
        \r\n\r\nProfessor of Cardiology, Institut de Cardiologie, Hôpital la Pitié-Salpêtrière, Paris, France\r\n\r\n
        `,
        disclosure: `
        Disclosure: Gilles Montalescot, MD, PhD, has disclosed the following relevant financial relationships:

        <br/>Served as an advisor or consultant for: Actelion Pharmaceuticals, Ltd; Amgen, Inc.; AstraZeneca Pharmaceuticals LP; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Lilly; Medtronic, Inc.; Menarini; Merck Sharp --AMPERSAND--amp; Dohme GmbH; Pfizer Inc.; sanofi-aventis
        
        <br/>Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Bayer AG; Bristol-Myers Squibb Company; Medtronic, Inc.; Pfizer Inc.; sanofi-aventis
        `
    },
    {
        title: "Anticoagulation Management Steering Committee",
        name: "Christian T. Ruff, MD, MPH",
        affiliation: `
        Assistant Professor of Medicine, TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School Boston, Massachusetts
        `,
        disclosure: `
        Disclosure: Christian T. Ruff, MD, MPH, has disclosed the following relevant financial relationships:

        <br/>Served as an advisor or consultant for: Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Portola Pharmaceuticals
        
        <br/>Received grants for clinical research from: Daiichi Sankyo, Inc.
        `
    },    
    {
        title: "Anticoagulation Management Steering Committee",
        name: "Mike Sharma, MD, MSc, FRCPC",
        affiliation: `
        Associate Professor, Division of Neurology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
        `,
        disclosure: `
        Disclosure: Mike Sharma, MD, MSc, FRCPC, has disclosed the following relevant financial relationships:

        <br/>Served as an advisor or consultant for: AZTherapies, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; 
        
        <br/>Served as a speaker or a member of a speakers bureau for: Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company
        `
    },
    {
        title: "Anticoagulation Management Steering Committee",
        name: "Peter Verhamme, MD, PhD",
        affiliation: `
        Professor, University of Leuven, Leuven, Belgium
        `,
        disclosure: `
        Disclosure: Peter Verhamme, MD, PhD, has disclosed the following relevant financial relationships: 

        <br/>Served as an advisor or consultant for: Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; LEO Pharma; Medtronic, Inc.; Pfizer Inc; Portola Pharmaceuticals
        
        <br/>Served as a speaker or a member of a speakers bureau for: Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; LEO Pharma; Pfizer Inc
        
        <br/>Received grants for clinical research from: Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; LEO Pharma; Sanofi 
        `
    },
    {
        title: "Anticoagulation Management Steering Committee",
        name: "Atul Verma, MD, FRCPC, FHRS",
        affiliation: `
        Associate Professor, University of Toronto; Director, Heart Rhythm Program, Southlake Regional Health Center, University of Toronto, Newmarket, Ontario, Canada
        `,
        disclosure: `
        Disclosure: Atul Verma, MD, FRCPC, FHRS, has disclosed the following relevant financial relationships:

        <br/>Served as an advisor or consultant for: Bayer HealthCare; Biosense Webster, Inc.; Medtronic, Inc.
        
        <br/>Served as a speaker or a member of a speakers bureau for: Bayer HealthCare; SERVIER
        
        <br/>Received grants for clinical research from: Bayer HealthCare; Biosense Webster, Inc.; Medtronic, Inc. 
        `
    },
    {
        title: "Vascular Protection Steering Committee",
        name: "Keith A.A. Fox, MBChB, FRCP, FMedSci",
        affiliation: `
        Professor of Cardiology, University of Edinburgh, Edinburgh, United Kingdom
        `,
        disclosure: `
        Disclosure: As listed above.
        `
    },
    {
        title: "Vascular Protection Steering Committee",
        name: "Victor Aboyans, MD, PhD",
        affiliation: `
        Professor; Head of Department of Cardiology, Dupuytren University Hospital, Limoges, France
        `,
        disclosure: `
        Disclosure: Victor Aboyans, MD, PhD, has disclosed the following relevant financial relationships: 

        <br/>Served as an advisor or consultant for: Bayer AG

        <br/>Served as a speaker or a member of a speakers bureau for: Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.
        `
    },
    {
        title: "Vascular Protection Steering Committee",
        name: "Deepak L. Bhatt, MD, MPH",
        affiliation: `
        Professor of Medicine, Harvard Medical School; Executive Director, Interventional Cardiovascular Programs, Brigham and Women's Hospital Heart --AMPERSAND--amp; Vascular Center, Boston, Massachusetts
        `,
        disclosure: `
        Disclosure: Deepak L. Bhatt, MD, MPH, has disclosed the following relevant financial relationships: 

        <br/>Received grants for clinical research from: Amarin Corporation plc; Amgen Inc.; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Chiesi Pharmaceuticals, Inc.; Eisai Inc.; Ethicon, Inc.; Forest Laboratories, Inc.; Ironwood Pharmaceuticals, Inc.; Ischemix, Inc.; Lilly; Medtronic, Inc.; Pfizer Inc.; Roche; sanofi-aventis; The Medicines Company; 
        `
    },
    {
        title: "Vascular Protection Steering Committee",
        name: "Christoph Bode, MD",
        affiliation: `
        Professor and Chairman, Cardiology and Angiology, Heart Center Freiburg University, Freiburg, Germany
        `,
        disclosure: `
        Disclosure: Christoph Bode, MD, has disclosed the following relevant financial relationships: 

        <br/>Served as an advisor or consultant for: Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Merck Sharp --AMPERSAND--amp; Dohme GmbH
        `
    },
    {
        title: "Vascular Protection Steering Committee",
        name: "Martin R. Cowie, MD, MSc, FRCP, FRCP (Ed), FESC",
        affiliation: `
        Professor of Cardiology, Imperial College London, Royal Brompton Hospital, London, United Kingdom
        `,
        disclosure: `
        Disclosure: Martin R. Cowie, MD, MSc, FRCP, FRCP (Ed), FESC, has disclosed the following relevant financial relationships: 

        <br/>Served as an advisor or consultant for:  Abbott Laboratories; Bayer AG; Boston Scientific; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; SERVIER
        
        <br/>Served as a speaker or a member of a speakers bureau for: Abbott Laboratories; Bayer AG; Boston Scientific; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; Roche; SERVIER
        
        <br/>Received grants for clinical research from: Bayer AG; Boston Scientific; Medtronic, Inc.; ResMed; Roche
        `
    },
    {
        title: "Vascular Protection Steering Committee",
        name: "John W. Eikelboom, MBBS, MSc",
        affiliation: `
        Associate Professor, Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
        `,
        disclosure: `
        Disclosure: John W. Eikelboom, MBBS, MSc, has disclosed the following relevant financial relationships:

        <br/>Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Janssen Pharmaceuticals, Inc.; Pfizer Inc. 
        
        <br/>Received grants for clinical research from: Bayer AG; Daiichi Sankyo, Inc.; GlaxoSmithKline; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; sanofi-aventis
        `
    },
    {
        title: "Vascular Protection Steering Committee",
        name: "Manesh R. Patel, MD",
        affiliation: `
        Professor of Medicine, Duke University Medical Center, Durham, North Carolina, United States
        `,
        disclosure: `
        Disclosure: Manesh R. Patel, MD, has disclosed the following relevant financial relationships: 

        <br/>Served as an advisor or consultant for:  Bayer AG; Genzyme Corporation; Janssen Pharmaceuticals, Inc.
        
        <br/>Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Johnson--ENTITY#160;----AMPERSAND--amp;--ENTITY#160;--Johnson Pharmaceutical Research --AMPERSAND--amp; Development, L.L.C.; MAQUET, Inc.; Tryton Medical
        `
    }
];